https://doi.org/10.1016/j.ijbiomac.2020.07.098
R
Ravi Kant
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
170
Papers
3.2K
Citations
31
h-index
63
i10-index
Ravi Kant is an academic researcher from University of Delhi. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Probiotics and Fermented Foods & Genomics and Phylogenetic Studies. The author has an h-index of 31, co-authored 145 publications.
ORCID: 0000-0003-3878-9775Papers by this author
worksChitin and its derivatives: Structural properties and biomedical applications
2020 · International Journal of Biological Macromolecules · 213 citations
Comparative genomics of <i>Lactobacillus</i>
2010 · Microbial Biotechnology · 132 citations
https://doi.org/10.1111/j.1751-7915.2010.00215.x
Functional characterization of probiotic surface layer protein-carrying Lactobacillus amylovorus strains
2014 · BMC Microbiology · 44 citations
https://doi.org/10.1186/1471-2180-14-199
Time-series sewage metagenomics distinguishes seasonal, human-derived and environmental microbial communities potentially allowing source-attributed surveillance
2024 · Nature Communications · 39 citations
https://doi.org/10.1038/s41467-024-51957-8
Ancestral allele of DNA polymerase gamma modifies antiviral tolerance
2024 · Nature · 26 citations
https://doi.org/10.1038/s41586-024-07260-z
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants
2023 · Nature Communications · 17 citations
https://doi.org/10.1038/s41467-023-37290-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat